Market players in key import markets noted that ibuprofen prices continued to follow an upward trend. The market in the US was at the epicenter of this price movement in December 2025 and January 2026. Prices remained stable before rising in December as increasing API costs put pressure on importers. The US market, which relied heavily on imported API, especially from Asian sources, was sensitive to inflation in API costs. The rising costs of raw materials, intermediate chemicals, utilities, and regulatory compliance added to the cost of producing ibuprofen. These rising costs were passed down the supply chain, eventually leading to higher offer prices to buyers in US Logistics and freight costs, which remained high, helped to strengthen the bullish trend. These costs included transportation costs, insurance costs, and port risks, all of which remained high. This trend was maintained in January 2026 as well. In the coming days, it is predicted that the prices of ibuprofen will remain high due to supply-side factors and will not come down anytime soon.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
